1st Quarter - Report

NATIONAL COMMUNITY PHARMACISTS ASSOCIATION for NATIONAL COMMUNITY PHARMACISTS ASSOCIATION

Firm
Client
Income
—
Expenses
$370,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

8 issue areas, each in the filer's own words, with who lobbied on it and where.

Animals ANI

Issues related to compounded pharmaceuticals for animals;

LobbyistCovered position, as disclosed
RONNA HAUSER —
KARRY LA VIOLETTE —
SUSAN PILCH —
MICHAEL TOMBERLIN —

Contacted: White House Office; Drug Enforcement Administration (DEA); Health Resources & Services Administration (HRSA); Government Accountability Office (GAO); Centers For Medicare and Medicaid Services (CMS); Office of Personnel Management (OPM); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Office of Natl Drug Control Policy (NDCP); Food & Drug Administration (FDA); Defense, Dept of (DOD); Medicare Payment Advisory Commission (MedPAC); Agriculture, Dept of (USDA); Office of Management & Budget (OMB); SENATE

Alcohol and Drug Abuse ALC

Implementation of Public Law 114-198 pharmacy provisions; Implementation of Public Law 114-255 pharmacy provisions;

LobbyistCovered position, as disclosed
RONNA HAUSER —
KARRY LA VIOLETTE —
SUSAN PILCH —
MICHAEL TOMBERLIN —

Contacted: Centers For Medicare and Medicaid Services (CMS); White House Office; Office of Natl Drug Control Policy (NDCP); Medicare Payment Advisory Commission (MedPAC); Agriculture, Dept of (USDA); Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS); Government Accountability Office (GAO); Drug Enforcement Administration (DEA); Office of Personnel Management (OPM); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Defense, Dept of (DOD); Health Resources & Services Administration (HRSA)

Taxation/Internal Revenue Code TAX

Small Business Tax Reform; H.R. 631, Death Tax Repeal Act of 2017; S. 205, Death Tax Repeal Act of 2017

LobbyistCovered position, as disclosed
RONNA HAUSER —
KARRY LA VIOLETTE —
SUSAN PILCH —
MICHAEL TOMBERLIN —

Contacted: Centers For Medicare and Medicaid Services (CMS); Office of Personnel Management (OPM); Food & Drug Administration (FDA); SENATE; Drug Enforcement Administration (DEA); HOUSE OF REPRESENTATIVES; Defense, Dept of (DOD); Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); White House Office; Health Resources & Services Administration (HRSA); Medicare Payment Advisory Commission (MedPAC); Office of Natl Drug Control Policy (NDCP); Agriculture, Dept of (USDA); Government Accountability Office (GAO)

Bills named: S. 205 (115th), H.R. 631 (115th)

Defense DEF

TRICARE Pharmacy Benefit Provisions; Supporting implementation of Sec. 745 of National Defense Authorization Act for Fiscal Year 2017;

LobbyistCovered position, as disclosed
RONNA HAUSER —
KARRY LA VIOLETTE —
SUSAN PILCH —
MICHAEL TOMBERLIN —

Contacted: HOUSE OF REPRESENTATIVES; Agriculture, Dept of (USDA); Food & Drug Administration (FDA); Drug Enforcement Administration (DEA); Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); White House Office; Office of Personnel Management (OPM); Government Accountability Office (GAO); Defense, Dept of (DOD); Medicare Payment Advisory Commission (MedPAC); Office of Natl Drug Control Policy (NDCP); SENATE

Health Issues HCR

H.R. 1628, American Health Care Act; Issues related to legislation repealing and replacing the affordable care act; S. 637, Creating Transparency to Have Drug Rebates Unlocked (C-Thru) Act of 2017; S. 222, The Obama Care Replacement Act' S. 469, Affordable and Safe Prescription Drug Importation Act; H.R. 1245, Affordable and Safe Prescription Drug Importation Act; H.R. 1776, Improving Access to Affordable Prescription Drugs Act; S. 771, Improving Access to Affordable Prescription Drugs Act; H.R. 242, Medicare Prescription Drug Price Negotiation Act of 2017; S. 41, Medicare Prescription Drug Price Negotiation Act of 2017;

LobbyistCovered position, as disclosed
RONNA HAUSER —
KARRY LA VIOLETTE —
SUSAN PILCH —
MICHAEL TOMBERLIN —

Contacted: Government Accountability Office (GAO); Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); Drug Enforcement Administration (DEA); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); Defense, Dept of (DOD); SENATE; Food & Drug Administration (FDA); Office of Natl Drug Control Policy (NDCP); Medicare Payment Advisory Commission (MedPAC); White House Office; Agriculture, Dept of (USDA); Office of Personnel Management (OPM)

Bills named: S. 41 (115th), S. 222 (115th), H.R. 242 (115th), H.R. 1628 (115th), S. 637 (115th), H.R. 1245 (115th), H.R. 1776 (115th), S. 469 (115th), S. 771 (115th)

Medicare/Medicaid MMM

H.R. 1316, Prescription Drug Price Transparency Act; H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act; S. 413, Improving Transparency and Accuracy in Medicare Part D Spending Act; H.R. 592, Pharmacy and Medically Underserved Areas Enhancement Act; S. 109, Pharmacy and Medically Underserved Areas Enhancement Act; H.R.1939 - To amend title XVIII of the Social Security Act to ensure equal access of Medicare beneficiaries to community pharmacies in underserved areas as network pharmacies under Medicare prescription drug coverage, and for other purposes

LobbyistCovered position, as disclosed
RONNA HAUSER —
KARRY LA VIOLETTE —
SUSAN PILCH —
MICHAEL TOMBERLIN —

Contacted: Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); SENATE; Health & Human Services, Dept of (HHS); Office of Personnel Management (OPM); HOUSE OF REPRESENTATIVES; Agriculture, Dept of (USDA); Government Accountability Office (GAO); Food & Drug Administration (FDA); Office of Natl Drug Control Policy (NDCP); Drug Enforcement Administration (DEA); Defense, Dept of (DOD); Office of Management & Budget (OMB); Medicare Payment Advisory Commission (MedPAC); White House Office

Bills named: H.R. 1316 (115th), S. 413 (115th), H.R. 592 (115th), H.R. 1038 (115th), S. 109 (115th), H.R. 1939 (115th)

Budget/Appropriations BUD

Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act; Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, specifically FDA funding for implementation of the Drug Quality and Security Act.

LobbyistCovered position, as disclosed
RONNA HAUSER —
KARRY LA VIOLETTE —
SUSAN PILCH —
MICHAEL TOMBERLIN —

Contacted: Health Resources & Services Administration (HRSA); Office of Management & Budget (OMB); Defense, Dept of (DOD); Food & Drug Administration (FDA); Drug Enforcement Administration (DEA); Centers For Medicare and Medicaid Services (CMS); SENATE; Agriculture, Dept of (USDA); White House Office; Office of Personnel Management (OPM); HOUSE OF REPRESENTATIVES; Government Accountability Office (GAO); Medicare Payment Advisory Commission (MedPAC); Health & Human Services, Dept of (HHS); Office of Natl Drug Control Policy (NDCP)

Pharmacy PHA

Congressional Oversight of 340 B Program; Issues related to FDA implementation of The Drug Quality and Security Act related to the regulations of pharmacy compounding; Biosimilar naming; H.R. 421 Allowing Greater Access to Safe and Effective Contraception Act

LobbyistCovered position, as disclosed
RONNA HAUSER —
KARRY LA VIOLETTE —
SUSAN PILCH —
MICHAEL TOMBERLIN —

Contacted: White House Office; Office of Personnel Management (OPM); Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); Agriculture, Dept of (USDA); Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); Medicare Payment Advisory Commission (MedPAC); Drug Enforcement Administration (DEA); Food & Drug Administration (FDA); Government Accountability Office (GAO); Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; Office of Natl Drug Control Policy (NDCP); SENATE

Bills named: H.R. 421 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.